<DOC>
	<DOC>NCT00422461</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and blood pressure lowering effect of different doses of PF-00489791 in patients with mild to moderate high blood pressure</brief_summary>
	<brief_title>A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>1. Males and/or Females of nonchildbearing potential between 18 and 70 years of age 2. History of mild to moderate hypertension 1. Type 1 or 2 diabetes on prescribed medications 2. Secondary, severe, or malignant hypertension 3. History of a significant cardiovascular event within the last 12 months of enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Clinical Trial, Randomized Controlled Trial, Humans, Cyclic Nucleotide Phosphodiesterases Type 5</keyword>
</DOC>